Speak to a 3D pRinting Expert
See how our 3D Printers can work best for your Research
Please fill the form below
Testimonials
“The M50 is wonderful; we totally depend on it for our COVID projects. Time is of the essence in nding solutions to the pandemic, and the printer allows us to test new microfluidic designs extremely fast. If there is ONE essential tool in our lab at the moment, this is it.”
During the call our 3D printing expert will explain the key features of the 3D printer and how this technology can work best for your research.
We have worked with several universities such as University of Toronto and UTS Sydney to name a few to help empower research.
CADworks3D was established in 2018 with the intention of providing exceptional user support, cost effective and microfluidic specific 3D printing solutions.
Featured Case Studies
Mar 20, 2020
- Zongjie Wang,
- Mark Gagliardi,
- Reza M. Mohamad,
- Sharif U. Ahmed,
- Mahmoud Labib,
- Libing Zhang,
- Sandra Popescu,
- Yuxiao Zhou,
- Edward H. Sargent,
- Gordon M. Keller and
- Shana O. Kelley
Abstract
The ability to detect rare human pluripotent stem cells (hPSCs) in differentiated populations is critical for safeguarding the clinical translation of cell therapy, as these undifferentiated cells have the capacity to form teratomas in vivo. The detection of hPSCs must be performed using an approach compatible with traceable manufacturing of therapeutic cell products. Here, we report a novel microfluidic approach, stem cell quantitative cytometry (SCQC), for the quantification of rare hPSCs in hPSC-derived cardiomyocyte (CM) populations. Read More
Apr 2, 2018
Mahmoud Labib, Reza M. Mohamadi, Mahla Poudineh, Sharif U. Ahmed, Ivaylo Ivanov, Ching-Lung Huang, Maral Moosavi, Edward H. Sargent & Shana O. Kelley
Abstract
Cell-to-cell variation in gene expression creates a need for techniques that can characterize expression at the level of individual cells. This is particularly true for rare circulating tumour cells, in which subtyping and drug resistance are of intense interest. Here we describe a method for cell analysis—single-cell mRNA cytometry—that enables the isolation of rare cells from whole blood as a function of target mRNA sequences. Read More
Feb 06, 2018
Mahla Poudineh, Edward H. Sargent, Klaus Pantel & Shana O. Kelley
Abstract
During cancer progression, many tumours shed circulating tumour cells (CTCs) and other biomarkers into the bloodstream. The analysis of CTCs offers the prospect of collecting a liquid biopsy from a patient’s blood to predict and monitor therapeutic responses and tumour recurrence. In this Review, we discuss progress towards the isolation and recovery of bulk CTCs from whole blood samples for the identification of cells with high metastatic potential. Read More
Nov 21, 2016
Mahla Poudineh, Peter M. Aldridge, Sharif Ahmed, Brenda J. Green, Leyla Kermanshah, Vivian Nguyen, Carmen Tu, Reza M. Mohamadi, Robert K. Nam, Aaron Hansen, Srikala S. Sridhar, Antonio Finelli, Neil E. Fleshner, Anthony M. Joshua5, Edward H. Sargent and Shana O. Kelley
Abstract
Profiling the heterogeneous phenotypes of rare circulating tumour cells (CTCs) in whole blood is critical to unravelling the complex and dynamic properties of these potential clinical markers. This task is challenging because these cells are present at parts per billion levels among normal blood cells. Here we report a new nanoparticle-enabled method for CTC characterization, called magnetic ranking cytometry, which profiles CTCs on the basis of their surface expression phenotype. We achieve this using a microfluidic chip that successfully processes whole blood samples. Read More